Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
5-Methylcytosine | 14 | 2021 | 154 | 3.440 |
Why?
|
Melanoma | 30 | 2023 | 5510 | 2.360 |
Why?
|
Cytosine | 5 | 2015 | 216 | 2.200 |
Why?
|
Skin Neoplasms | 27 | 2023 | 5686 | 1.920 |
Why?
|
Facial Transplantation | 12 | 2023 | 226 | 1.870 |
Why?
|
Graft Rejection | 27 | 2024 | 4397 | 1.240 |
Why?
|
Nevus | 3 | 2014 | 204 | 1.210 |
Why?
|
Nevus, Pigmented | 4 | 2017 | 219 | 1.160 |
Why?
|
Dioxygenases | 8 | 2021 | 316 | 1.110 |
Why?
|
Epigenesis, Genetic | 10 | 2019 | 3647 | 0.970 |
Why?
|
Sweat Gland Neoplasms | 2 | 2020 | 108 | 0.760 |
Why?
|
Proto-Oncogene Proteins c-myb | 1 | 2020 | 78 | 0.720 |
Why?
|
Precancerous Conditions | 2 | 2017 | 975 | 0.650 |
Why?
|
Skin | 13 | 2022 | 4364 | 0.630 |
Why?
|
Hair Follicle | 1 | 2019 | 209 | 0.580 |
Why?
|
Phthirus | 1 | 2016 | 1 | 0.570 |
Why?
|
Sweat Gland Diseases | 1 | 2016 | 11 | 0.570 |
Why?
|
Lice Infestations | 1 | 2016 | 8 | 0.570 |
Why?
|
Gene Expression Regulation, Neoplastic | 11 | 2021 | 8428 | 0.570 |
Why?
|
Cell Hypoxia | 1 | 2019 | 675 | 0.550 |
Why?
|
Ichthyosis, Lamellar | 1 | 2015 | 11 | 0.540 |
Why?
|
Lipoxygenase | 1 | 2015 | 74 | 0.540 |
Why?
|
Ascorbic Acid | 1 | 2019 | 651 | 0.520 |
Why?
|
Aristolochic Acids | 1 | 2014 | 8 | 0.510 |
Why?
|
Port-Wine Stain | 1 | 2014 | 33 | 0.510 |
Why?
|
Pyrrolizidine Alkaloids | 1 | 2014 | 10 | 0.510 |
Why?
|
Dermatitis | 1 | 2016 | 197 | 0.490 |
Why?
|
Codon, Nonsense | 1 | 2015 | 281 | 0.480 |
Why?
|
Facial Dermatoses | 1 | 2014 | 87 | 0.480 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2014 | 100 | 0.480 |
Why?
|
Graft vs Host Reaction | 1 | 2014 | 104 | 0.470 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2018 | 602 | 0.460 |
Why?
|
Skin Transplantation | 7 | 2022 | 1074 | 0.460 |
Why?
|
Carcinoma, Small Cell | 1 | 2015 | 420 | 0.450 |
Why?
|
Proto-Oncogene Proteins | 7 | 2021 | 4554 | 0.450 |
Why?
|
DNA-Binding Proteins | 11 | 2021 | 9648 | 0.440 |
Why?
|
Carcinogens | 1 | 2014 | 466 | 0.410 |
Why?
|
Ultraviolet Rays | 2 | 2018 | 1060 | 0.410 |
Why?
|
Mouth Neoplasms | 1 | 2017 | 601 | 0.410 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2021 | 4034 | 0.390 |
Why?
|
Homozygote | 1 | 2015 | 1785 | 0.380 |
Why?
|
Epigenomics | 1 | 2015 | 903 | 0.360 |
Why?
|
Stem Cells | 4 | 2022 | 3567 | 0.360 |
Why?
|
Autoimmunity | 2 | 2022 | 1349 | 0.360 |
Why?
|
Lupus Erythematosus, Cutaneous | 2 | 2020 | 58 | 0.360 |
Why?
|
Pityriasis Rubra Pilaris | 2 | 2020 | 12 | 0.350 |
Why?
|
Cicatrix, Hypertrophic | 2 | 2024 | 79 | 0.350 |
Why?
|
DNA Methylation | 9 | 2021 | 4286 | 0.340 |
Why?
|
Pemphigoid, Bullous | 2 | 2020 | 109 | 0.320 |
Why?
|
Fibroblasts | 1 | 2019 | 4161 | 0.320 |
Why?
|
Immune Tolerance | 5 | 2023 | 2258 | 0.320 |
Why?
|
Drug Hypersensitivity | 1 | 2016 | 884 | 0.310 |
Why?
|
Immunohistochemistry | 8 | 2022 | 11366 | 0.300 |
Why?
|
Evolution, Molecular | 1 | 2016 | 1940 | 0.290 |
Why?
|
Cell Differentiation | 5 | 2022 | 11483 | 0.290 |
Why?
|
Fluorescent Antibody Technique | 3 | 2017 | 2505 | 0.280 |
Why?
|
Lymphatic Metastasis | 1 | 2014 | 2924 | 0.280 |
Why?
|
Cell Proliferation | 5 | 2019 | 10481 | 0.270 |
Why?
|
Gene Expression Profiling | 5 | 2018 | 9438 | 0.270 |
Why?
|
Keratinocytes | 3 | 2019 | 798 | 0.260 |
Why?
|
Humans | 91 | 2024 | 744343 | 0.260 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 2 | 2018 | 207 | 0.260 |
Why?
|
Lymph Nodes | 3 | 2024 | 3474 | 0.250 |
Why?
|
T-Lymphocytes | 8 | 2020 | 10180 | 0.250 |
Why?
|
Animals | 50 | 2024 | 168757 | 0.240 |
Why?
|
Bone Morphogenetic Proteins | 2 | 2021 | 838 | 0.240 |
Why?
|
Receptor, Angiotensin, Type 1 | 3 | 2010 | 152 | 0.240 |
Why?
|
Immunoconjugates | 5 | 2003 | 901 | 0.230 |
Why?
|
Receptors, Nerve Growth Factor | 2 | 2021 | 200 | 0.230 |
Why?
|
Complement Factor H | 1 | 2024 | 110 | 0.230 |
Why?
|
Neoplasm Metastasis | 6 | 2021 | 4851 | 0.230 |
Why?
|
Immunoenzyme Techniques | 2 | 2017 | 1799 | 0.220 |
Why?
|
Mice | 36 | 2024 | 81183 | 0.220 |
Why?
|
Transplantation, Homologous | 9 | 2023 | 4776 | 0.220 |
Why?
|
Diabetes Mellitus, Experimental | 3 | 2021 | 1116 | 0.220 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2727 | 0.220 |
Why?
|
Aldosterone | 3 | 2010 | 877 | 0.210 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2018 | 713 | 0.210 |
Why?
|
CD8-Positive T-Lymphocytes | 7 | 2022 | 4479 | 0.210 |
Why?
|
Neoplasm Staging | 2 | 2018 | 11031 | 0.210 |
Why?
|
Male | 47 | 2021 | 350118 | 0.200 |
Why?
|
Biopsy | 9 | 2021 | 6756 | 0.200 |
Why?
|
Angiotensin II | 3 | 2010 | 881 | 0.200 |
Why?
|
Retinal Degeneration | 2 | 2016 | 415 | 0.200 |
Why?
|
Graft Survival | 8 | 2024 | 3737 | 0.200 |
Why?
|
Myxoma | 1 | 2022 | 130 | 0.200 |
Why?
|
Skin Diseases | 2 | 2022 | 1065 | 0.190 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2023 | 2455 | 0.190 |
Why?
|
Antibodies, Monoclonal | 4 | 2018 | 9274 | 0.190 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 2 | 2019 | 182 | 0.190 |
Why?
|
Immunization, Passive | 1 | 2003 | 623 | 0.190 |
Why?
|
Middle Aged | 29 | 2021 | 213383 | 0.190 |
Why?
|
Paget Disease, Extramammary | 1 | 2021 | 45 | 0.190 |
Why?
|
Genital Neoplasms, Male | 1 | 2021 | 74 | 0.190 |
Why?
|
Limbus Corneae | 1 | 2022 | 144 | 0.190 |
Why?
|
Aged, 80 and over | 10 | 2021 | 57776 | 0.190 |
Why?
|
Activating Transcription Factor 3 | 1 | 2020 | 54 | 0.190 |
Why?
|
Penile Diseases | 1 | 2020 | 46 | 0.180 |
Why?
|
Lupus Erythematosus, Discoid | 1 | 2020 | 49 | 0.180 |
Why?
|
Pyoderma Gangrenosum | 1 | 2021 | 76 | 0.180 |
Why?
|
NG-Nitroarginine Methyl Ester | 3 | 2010 | 255 | 0.180 |
Why?
|
Scleroderma, Localized | 1 | 2020 | 79 | 0.180 |
Why?
|
Fasciitis | 1 | 2020 | 65 | 0.180 |
Why?
|
Angiomatosis | 1 | 2020 | 49 | 0.180 |
Why?
|
Th1 Cells | 3 | 2016 | 1057 | 0.180 |
Why?
|
Scrotum | 1 | 2020 | 115 | 0.180 |
Why?
|
Epithelium, Corneal | 1 | 2022 | 247 | 0.180 |
Why?
|
Mutation | 5 | 2016 | 29786 | 0.170 |
Why?
|
Skin Diseases, Vascular | 1 | 2020 | 39 | 0.170 |
Why?
|
Keratin-15 | 1 | 2019 | 22 | 0.170 |
Why?
|
Edema | 1 | 2023 | 789 | 0.170 |
Why?
|
Ice | 1 | 2020 | 104 | 0.170 |
Why?
|
Aged | 21 | 2021 | 163280 | 0.170 |
Why?
|
Melanosis | 1 | 2019 | 78 | 0.170 |
Why?
|
Paraneoplastic Syndromes | 1 | 2020 | 151 | 0.170 |
Why?
|
Liver | 1 | 2014 | 7474 | 0.160 |
Why?
|
Intestines | 4 | 2006 | 1924 | 0.160 |
Why?
|
Neural Crest | 1 | 2021 | 275 | 0.160 |
Why?
|
Dermatitis, Exfoliative | 1 | 2018 | 28 | 0.160 |
Why?
|
Heart Neoplasms | 1 | 2022 | 374 | 0.160 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2018 | 134 | 0.160 |
Why?
|
Immunosuppressive Agents | 8 | 2022 | 4149 | 0.160 |
Why?
|
Female | 42 | 2024 | 380194 | 0.160 |
Why?
|
Growth Differentiation Factor 6 | 1 | 2017 | 8 | 0.160 |
Why?
|
Leukemic Infiltration | 1 | 2018 | 48 | 0.160 |
Why?
|
Adenylate Kinase | 1 | 2018 | 100 | 0.160 |
Why?
|
Dermatomyositis | 1 | 2020 | 224 | 0.160 |
Why?
|
Nasal Mucosa | 1 | 2020 | 373 | 0.150 |
Why?
|
Mouth Mucosa | 1 | 2020 | 434 | 0.150 |
Why?
|
Mice, Inbred C3H | 7 | 2006 | 964 | 0.150 |
Why?
|
Melanins | 1 | 2019 | 289 | 0.150 |
Why?
|
Models, Biological | 1 | 2014 | 9583 | 0.150 |
Why?
|
Signal Transduction | 11 | 2021 | 23403 | 0.150 |
Why?
|
Chemokines | 1 | 2022 | 970 | 0.150 |
Why?
|
Up-Regulation | 3 | 2019 | 4217 | 0.150 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 2 | 2015 | 140 | 0.150 |
Why?
|
Mucous Membrane | 1 | 2020 | 673 | 0.150 |
Why?
|
Cells, Cultured | 5 | 2022 | 19229 | 0.150 |
Why?
|
Lichen Planus, Oral | 1 | 2017 | 56 | 0.140 |
Why?
|
Transplantation Tolerance | 2 | 2003 | 617 | 0.140 |
Why?
|
Cicatrix | 2 | 2020 | 764 | 0.140 |
Why?
|
Subcutaneous Fat | 1 | 2020 | 391 | 0.140 |
Why?
|
CD4-Positive T-Lymphocytes | 6 | 2018 | 4386 | 0.140 |
Why?
|
Epidermis | 1 | 2019 | 528 | 0.140 |
Why?
|
Mycosis Fungoides | 1 | 2018 | 163 | 0.140 |
Why?
|
Neoplasms | 7 | 2022 | 21683 | 0.140 |
Why?
|
Protein-Lysine 6-Oxidase | 1 | 2016 | 60 | 0.140 |
Why?
|
Adult | 22 | 2021 | 214055 | 0.140 |
Why?
|
Granuloma, Foreign-Body | 1 | 2016 | 45 | 0.140 |
Why?
|
Eosinophilia | 1 | 2020 | 541 | 0.140 |
Why?
|
Talc | 1 | 2016 | 47 | 0.140 |
Why?
|
MutS Homolog 2 Protein | 1 | 2016 | 200 | 0.130 |
Why?
|
Exanthema | 1 | 2020 | 501 | 0.130 |
Why?
|
Interleukin-2 | 1 | 2023 | 1904 | 0.130 |
Why?
|
Antineoplastic Agents | 3 | 2018 | 13695 | 0.130 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2016 | 215 | 0.130 |
Why?
|
Adenoma, Sweat Gland | 1 | 2015 | 18 | 0.130 |
Why?
|
Tissue Donors | 2 | 2014 | 2240 | 0.130 |
Why?
|
Protective Agents | 1 | 2017 | 156 | 0.130 |
Why?
|
Antigens, Differentiation | 4 | 2001 | 927 | 0.130 |
Why?
|
Ceramides | 1 | 2017 | 199 | 0.130 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2022 | 2942 | 0.130 |
Why?
|
Fibroma | 1 | 2017 | 212 | 0.130 |
Why?
|
Estradiol | 2 | 2008 | 2020 | 0.130 |
Why?
|
Neisseriaceae Infections | 1 | 2014 | 5 | 0.130 |
Why?
|
Receptor, EphA3 | 1 | 2014 | 13 | 0.130 |
Why?
|
Genes, myb | 1 | 2014 | 18 | 0.130 |
Why?
|
Cryosurgery | 1 | 2020 | 453 | 0.130 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2021 | 835 | 0.130 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2019 | 627 | 0.130 |
Why?
|
Methyltransferases | 1 | 2018 | 367 | 0.130 |
Why?
|
Purpura Fulminans | 1 | 2014 | 22 | 0.130 |
Why?
|
Naphthalenes | 1 | 2015 | 194 | 0.120 |
Why?
|
Rats, Transgenic | 1 | 2014 | 72 | 0.120 |
Why?
|
Leukemia, Myeloid | 1 | 2018 | 707 | 0.120 |
Why?
|
Face | 1 | 2020 | 994 | 0.120 |
Why?
|
Gene Rearrangement | 1 | 2020 | 1179 | 0.120 |
Why?
|
Facial Neoplasms | 1 | 2015 | 121 | 0.120 |
Why?
|
Tissue Array Analysis | 1 | 2016 | 553 | 0.120 |
Why?
|
Paracrine Communication | 1 | 2016 | 277 | 0.120 |
Why?
|
Protein Processing, Post-Translational | 2 | 2014 | 1990 | 0.120 |
Why?
|
Histocompatibility Testing | 1 | 2016 | 741 | 0.120 |
Why?
|
Facial Injuries | 1 | 2015 | 183 | 0.120 |
Why?
|
Interleukin-17 | 2 | 2020 | 899 | 0.120 |
Why?
|
Mice, Nude | 5 | 2020 | 3689 | 0.120 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2016 | 890 | 0.120 |
Why?
|
Zebrafish | 2 | 2022 | 2994 | 0.120 |
Why?
|
Intestine, Small | 3 | 2001 | 1241 | 0.120 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 188 | 0.120 |
Why?
|
Immunoblotting | 1 | 2017 | 1682 | 0.120 |
Why?
|
Interleukin-6 | 2 | 2022 | 3200 | 0.120 |
Why?
|
Bone Marrow Cells | 2 | 2016 | 2513 | 0.120 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2017 | 450 | 0.120 |
Why?
|
Axilla | 1 | 2016 | 595 | 0.120 |
Why?
|
Consanguinity | 1 | 2015 | 454 | 0.120 |
Why?
|
Immunoprecipitation | 1 | 2016 | 905 | 0.110 |
Why?
|
Neoplasm Proteins | 2 | 2017 | 3703 | 0.110 |
Why?
|
Proteinuria | 1 | 2006 | 658 | 0.110 |
Why?
|
Cell Movement | 3 | 2019 | 5217 | 0.110 |
Why?
|
Rats | 8 | 2024 | 24260 | 0.110 |
Why?
|
Lymphedema | 1 | 2020 | 534 | 0.110 |
Why?
|
Rats, Inbred F344 | 1 | 2014 | 862 | 0.110 |
Why?
|
Liver Diseases | 1 | 2022 | 1253 | 0.110 |
Why?
|
Prognosis | 7 | 2018 | 29063 | 0.110 |
Why?
|
Cluster Analysis | 2 | 2018 | 2715 | 0.110 |
Why?
|
Trans-Activators | 3 | 2016 | 2924 | 0.110 |
Why?
|
Soft Tissue Infections | 1 | 2014 | 155 | 0.110 |
Why?
|
Brachytherapy | 1 | 2021 | 1248 | 0.110 |
Why?
|
Melanocytes | 2 | 2015 | 515 | 0.110 |
Why?
|
Kidney Diseases | 1 | 2024 | 2149 | 0.110 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2023 | 3336 | 0.110 |
Why?
|
Mice, Inbred C57BL | 15 | 2022 | 21827 | 0.110 |
Why?
|
Neoplasms, Second Primary | 1 | 2020 | 1061 | 0.100 |
Why?
|
Immunotherapy | 5 | 2021 | 4445 | 0.100 |
Why?
|
Erythropoietin | 1 | 2017 | 726 | 0.100 |
Why?
|
Myocardium | 4 | 2010 | 4776 | 0.100 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2021 | 2938 | 0.100 |
Why?
|
Matrix Metalloproteinases | 1 | 2014 | 391 | 0.100 |
Why?
|
Mice, Inbred NOD | 3 | 2023 | 1878 | 0.100 |
Why?
|
Early Diagnosis | 1 | 2017 | 1184 | 0.100 |
Why?
|
Interferon-gamma | 3 | 2016 | 3206 | 0.100 |
Why?
|
Histones | 2 | 2014 | 2599 | 0.100 |
Why?
|
Diet, Sodium-Restricted | 1 | 2013 | 287 | 0.100 |
Why?
|
Lymphotoxin-alpha | 1 | 2001 | 96 | 0.100 |
Why?
|
Psoriasis | 1 | 2019 | 898 | 0.100 |
Why?
|
RNA, Neoplasm | 1 | 2014 | 769 | 0.100 |
Why?
|
Retina | 3 | 2017 | 2616 | 0.100 |
Why?
|
Heart | 3 | 2013 | 4467 | 0.100 |
Why?
|
Pedigree | 2 | 2016 | 4644 | 0.100 |
Why?
|
Mice, Inbred BALB C | 7 | 2017 | 6386 | 0.100 |
Why?
|
Dermatology | 1 | 2021 | 872 | 0.090 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2023 | 2988 | 0.090 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 1038 | 0.090 |
Why?
|
Graft Enhancement, Immunologic | 2 | 2006 | 59 | 0.090 |
Why?
|
Retinal Diseases | 1 | 2017 | 683 | 0.090 |
Why?
|
RNA, Untranslated | 1 | 2014 | 453 | 0.090 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2016 | 496 | 0.090 |
Why?
|
Models, Animal | 4 | 2021 | 2171 | 0.090 |
Why?
|
Retrospective Studies | 12 | 2024 | 77449 | 0.090 |
Why?
|
Germ-Line Mutation | 1 | 2018 | 1788 | 0.090 |
Why?
|
DNA Mutational Analysis | 2 | 2016 | 4186 | 0.090 |
Why?
|
Nitric Oxide Synthase Type III | 2 | 2010 | 689 | 0.090 |
Why?
|
Sodium, Dietary | 1 | 2013 | 418 | 0.090 |
Why?
|
Disease Models, Animal | 6 | 2019 | 18029 | 0.090 |
Why?
|
Adiponectin | 2 | 2013 | 1100 | 0.090 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2014 | 709 | 0.090 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2018 | 2043 | 0.090 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2016 | 686 | 0.090 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2018 | 3557 | 0.090 |
Why?
|
DNA Helicases | 1 | 2014 | 859 | 0.080 |
Why?
|
Extremities | 1 | 2014 | 865 | 0.080 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2014 | 789 | 0.080 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2018 | 1596 | 0.080 |
Why?
|
DNA, Neoplasm | 1 | 2014 | 1758 | 0.080 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1692 | 0.080 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2020 | 3508 | 0.080 |
Why?
|
Cell Line, Tumor | 7 | 2019 | 16689 | 0.080 |
Why?
|
Th2 Cells | 2 | 2001 | 1061 | 0.080 |
Why?
|
Young Adult | 6 | 2019 | 56430 | 0.080 |
Why?
|
Hematologic Neoplasms | 1 | 2020 | 1832 | 0.080 |
Why?
|
Caveolin 1 | 1 | 2010 | 263 | 0.080 |
Why?
|
Lymphocyte Activation | 4 | 2016 | 5524 | 0.080 |
Why?
|
Tumor Microenvironment | 2 | 2021 | 3586 | 0.080 |
Why?
|
Models, Theoretical | 1 | 2020 | 3589 | 0.080 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4462 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 4 | 2016 | 17446 | 0.080 |
Why?
|
Histone Demethylases | 1 | 2010 | 321 | 0.080 |
Why?
|
Diabetes Mellitus | 2 | 2018 | 5751 | 0.080 |
Why?
|
Gene Expression | 2 | 2019 | 7799 | 0.080 |
Why?
|
Graft vs Host Disease | 1 | 2020 | 2957 | 0.070 |
Why?
|
Collagen | 1 | 2016 | 2689 | 0.070 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2012 | 871 | 0.070 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2014 | 1660 | 0.070 |
Why?
|
Cardiomegaly | 1 | 2010 | 620 | 0.070 |
Why?
|
Stem Cell Transplantation | 1 | 2016 | 1620 | 0.070 |
Why?
|
Regeneration | 1 | 2016 | 1485 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5535 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2015 | 3597 | 0.070 |
Why?
|
Glucose | 1 | 2018 | 4397 | 0.070 |
Why?
|
Surgical Flaps | 1 | 2015 | 1640 | 0.070 |
Why?
|
Receptors, Tumor Necrosis Factor | 2 | 2003 | 595 | 0.070 |
Why?
|
Gene Expression Regulation | 4 | 2016 | 12072 | 0.070 |
Why?
|
RNA Interference | 1 | 2014 | 2889 | 0.060 |
Why?
|
Antibodies | 2 | 2024 | 2460 | 0.060 |
Why?
|
Bone Marrow Transplantation | 2 | 2003 | 2765 | 0.060 |
Why?
|
Cell Cycle Proteins | 1 | 2016 | 3462 | 0.060 |
Why?
|
Mesenchymal Stem Cells | 1 | 2016 | 1632 | 0.060 |
Why?
|
Microphthalmia-Associated Transcription Factor | 2 | 2017 | 252 | 0.060 |
Why?
|
Apoptosis | 5 | 2020 | 9727 | 0.060 |
Why?
|
Heart Transplantation | 3 | 2003 | 3110 | 0.060 |
Why?
|
Follow-Up Studies | 5 | 2020 | 39050 | 0.060 |
Why?
|
Complement C3d | 1 | 2024 | 21 | 0.060 |
Why?
|
NF-kappa B | 1 | 2003 | 2499 | 0.060 |
Why?
|
Stromal Cells | 2 | 2022 | 1355 | 0.060 |
Why?
|
Mice, Knockout | 6 | 2018 | 14557 | 0.060 |
Why?
|
Rats, Wistar | 3 | 2008 | 1901 | 0.060 |
Why?
|
Spironolactone | 1 | 2006 | 382 | 0.060 |
Why?
|
CD40 Ligand | 2 | 2003 | 526 | 0.060 |
Why?
|
Receptors, Mineralocorticoid | 3 | 2010 | 164 | 0.060 |
Why?
|
RNA, Messenger | 7 | 2008 | 13033 | 0.050 |
Why?
|
Busulfan | 1 | 2003 | 263 | 0.050 |
Why?
|
Phenotype | 2 | 2022 | 16365 | 0.050 |
Why?
|
Kidney | 2 | 2006 | 7186 | 0.050 |
Why?
|
Laminin | 1 | 2024 | 419 | 0.050 |
Why?
|
Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2022 | 26 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2016 | 4042 | 0.050 |
Why?
|
Nuclear Proteins | 2 | 2014 | 5853 | 0.050 |
Why?
|
Cell Survival | 3 | 2017 | 5882 | 0.050 |
Why?
|
Antigens, CD | 5 | 2003 | 4026 | 0.050 |
Why?
|
Complement Activation | 1 | 2024 | 453 | 0.050 |
Why?
|
Estrogen Replacement Therapy | 1 | 2008 | 1203 | 0.050 |
Why?
|
Receptors, Interleukin-2 | 1 | 2003 | 573 | 0.050 |
Why?
|
Gene Knockdown Techniques | 2 | 2016 | 1655 | 0.050 |
Why?
|
STAT4 Transcription Factor | 2 | 2001 | 96 | 0.050 |
Why?
|
Mice, Neurologic Mutants | 1 | 2021 | 126 | 0.050 |
Why?
|
Sunlight | 1 | 2022 | 325 | 0.050 |
Why?
|
Chemokines, CC | 1 | 2022 | 291 | 0.050 |
Why?
|
Collagen Type I | 1 | 2024 | 592 | 0.050 |
Why?
|
Oncogene Protein v-akt | 1 | 2020 | 135 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2017 | 4838 | 0.050 |
Why?
|
Down-Regulation | 2 | 2019 | 3002 | 0.050 |
Why?
|
STAT6 Transcription Factor | 2 | 2001 | 199 | 0.050 |
Why?
|
Ovariectomy | 2 | 2008 | 661 | 0.050 |
Why?
|
Keratosis | 1 | 2020 | 81 | 0.050 |
Why?
|
Case-Control Studies | 4 | 2020 | 21746 | 0.050 |
Why?
|
Current Procedural Terminology | 1 | 2021 | 92 | 0.050 |
Why?
|
Histamine Antagonists | 1 | 2020 | 93 | 0.050 |
Why?
|
Glomerular Filtration Rate | 2 | 2020 | 2170 | 0.050 |
Why?
|
Histone-Lysine N-Methyltransferase | 2 | 2018 | 670 | 0.050 |
Why?
|
Acute Disease | 3 | 2018 | 7149 | 0.050 |
Why?
|
Pigmentation Disorders | 1 | 2020 | 101 | 0.040 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2021 | 373 | 0.040 |
Why?
|
Ear, External | 1 | 2020 | 161 | 0.040 |
Why?
|
Substance-Related Disorders | 1 | 2016 | 4258 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2020 | 4420 | 0.040 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2022 | 491 | 0.040 |
Why?
|
Injections, Intraperitoneal | 2 | 2000 | 425 | 0.040 |
Why?
|
Parotid Neoplasms | 1 | 2021 | 155 | 0.040 |
Why?
|
Hyperplasia | 1 | 2022 | 1185 | 0.040 |
Why?
|
Mucins | 1 | 2022 | 564 | 0.040 |
Why?
|
Antibodies, Antinuclear | 1 | 2020 | 326 | 0.040 |
Why?
|
Diabetic Nephropathies | 1 | 2006 | 984 | 0.040 |
Why?
|
Immunoglobulins | 1 | 2022 | 881 | 0.040 |
Why?
|
RNA | 2 | 2022 | 2749 | 0.040 |
Why?
|
Erythema | 1 | 2020 | 257 | 0.040 |
Why?
|
Histone Code | 1 | 2019 | 163 | 0.040 |
Why?
|
Adipokines | 2 | 2013 | 319 | 0.040 |
Why?
|
Administration, Topical | 1 | 2020 | 690 | 0.040 |
Why?
|
Lymphocyte Culture Test, Mixed | 2 | 2003 | 517 | 0.040 |
Why?
|
Injections, Subcutaneous | 1 | 2020 | 666 | 0.040 |
Why?
|
Sus scrofa | 1 | 2020 | 437 | 0.040 |
Why?
|
Cohort Studies | 2 | 2022 | 40561 | 0.040 |
Why?
|
Mixed Function Oxygenases | 1 | 2019 | 272 | 0.040 |
Why?
|
Upper Extremity | 1 | 2023 | 648 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2014 | 15519 | 0.040 |
Why?
|
Neoplasm Invasiveness | 2 | 2018 | 3616 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2018 | 6773 | 0.040 |
Why?
|
Melanoma-Specific Antigens | 1 | 2018 | 80 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2020 | 63114 | 0.040 |
Why?
|
Phosphorylation | 2 | 2020 | 8436 | 0.040 |
Why?
|
Enzyme Stability | 1 | 2018 | 210 | 0.040 |
Why?
|
Phosphoserine | 1 | 2018 | 206 | 0.040 |
Why?
|
MicroRNAs | 1 | 2014 | 3752 | 0.040 |
Why?
|
Ecosystem | 1 | 2022 | 474 | 0.040 |
Why?
|
Neoplasm, Residual | 1 | 2022 | 973 | 0.040 |
Why?
|
Embryo, Nonmammalian | 1 | 2021 | 895 | 0.040 |
Why?
|
Melanoma, Experimental | 1 | 2020 | 561 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2020 | 8642 | 0.040 |
Why?
|
Genome-Wide Association Study | 2 | 2014 | 12261 | 0.040 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 412 | 0.040 |
Why?
|
Aging | 1 | 2015 | 8664 | 0.040 |
Why?
|
Adipose Tissue | 3 | 2016 | 3279 | 0.040 |
Why?
|
Oligodendroglioma | 1 | 2018 | 279 | 0.040 |
Why?
|
Spleen | 3 | 2006 | 2362 | 0.040 |
Why?
|
Pancreas | 1 | 2023 | 1686 | 0.030 |
Why?
|
Opsins | 1 | 2016 | 18 | 0.030 |
Why?
|
Peyer's Patches | 1 | 2006 | 121 | 0.030 |
Why?
|
Extracellular Matrix | 1 | 2024 | 1741 | 0.030 |
Why?
|
Withholding Treatment | 1 | 2020 | 599 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 2010 | 7722 | 0.030 |
Why?
|
Adolescent | 4 | 2019 | 85781 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2023 | 1613 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2021 | 1549 | 0.030 |
Why?
|
Neck | 1 | 2020 | 697 | 0.030 |
Why?
|
Microscopy, Polarization | 1 | 2016 | 88 | 0.030 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2016 | 75 | 0.030 |
Why?
|
Estrogen Receptor beta | 1 | 2006 | 175 | 0.030 |
Why?
|
Atrophy | 1 | 2020 | 1583 | 0.030 |
Why?
|
Intravitreal Injections | 1 | 2017 | 344 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 2 | 2017 | 8301 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2016 | 8863 | 0.030 |
Why?
|
Survival Analysis | 2 | 2018 | 10252 | 0.030 |
Why?
|
Neurofibromin 1 | 1 | 2016 | 196 | 0.030 |
Why?
|
Transcription Factors | 1 | 2014 | 12208 | 0.030 |
Why?
|
Head | 1 | 2020 | 880 | 0.030 |
Why?
|
Dendritic Cells | 1 | 2006 | 2725 | 0.030 |
Why?
|
Base Sequence | 2 | 2016 | 12797 | 0.030 |
Why?
|
bcl-2-Associated X Protein | 1 | 2016 | 295 | 0.030 |
Why?
|
Neisseria meningitidis | 1 | 2014 | 109 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2006 | 480 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2022 | 2015 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 489 | 0.030 |
Why?
|
bcl-X Protein | 1 | 2016 | 411 | 0.030 |
Why?
|
Photoreceptor Cells, Vertebrate | 1 | 2016 | 204 | 0.030 |
Why?
|
Substrate Specificity | 1 | 2018 | 1801 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2023 | 2540 | 0.030 |
Why?
|
Osteocytes | 1 | 2016 | 197 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2023 | 9239 | 0.030 |
Why?
|
Cornea | 1 | 2022 | 1524 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2020 | 1240 | 0.030 |
Why?
|
Swine | 1 | 2024 | 5917 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2021 | 5172 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2016 | 684 | 0.030 |
Why?
|
Phylogeny | 1 | 2021 | 2803 | 0.030 |
Why?
|
Histocytochemistry | 1 | 2014 | 719 | 0.030 |
Why?
|
Antimalarials | 1 | 2020 | 905 | 0.030 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2016 | 599 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2020 | 1526 | 0.030 |
Why?
|
Caspase 3 | 1 | 2016 | 758 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2015 | 15295 | 0.030 |
Why?
|
Testosterone | 1 | 2024 | 2420 | 0.030 |
Why?
|
Triglycerides | 2 | 2013 | 2454 | 0.030 |
Why?
|
Vasoconstrictor Agents | 1 | 2006 | 642 | 0.030 |
Why?
|
Transplantation, Heterotopic | 1 | 2003 | 175 | 0.030 |
Why?
|
Immunity, Cellular | 2 | 2014 | 1607 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2016 | 767 | 0.030 |
Why?
|
Mice, Obese | 1 | 2013 | 424 | 0.030 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2015 | 449 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3527 | 0.030 |
Why?
|
Judgment | 1 | 2014 | 281 | 0.030 |
Why?
|
Estrogen Receptor alpha | 1 | 2006 | 577 | 0.030 |
Why?
|
Sirolimus | 1 | 2020 | 1564 | 0.030 |
Why?
|
Tumor Necrosis Factor Ligand Superfamily Member 14 | 1 | 2001 | 9 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor, Member 14 | 1 | 2001 | 12 | 0.030 |
Why?
|
Monocytes | 1 | 2022 | 2596 | 0.030 |
Why?
|
Cytokines | 2 | 2022 | 7322 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2021 | 2503 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2022 | 1863 | 0.030 |
Why?
|
Hepatitis C, Chronic | 1 | 2020 | 1031 | 0.020 |
Why?
|
Reoperation | 1 | 2021 | 4201 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1855 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2015 | 2085 | 0.020 |
Why?
|
Child | 2 | 2019 | 77709 | 0.020 |
Why?
|
Metformin | 1 | 2018 | 835 | 0.020 |
Why?
|
Disease Progression | 2 | 2018 | 13284 | 0.020 |
Why?
|
Family Health | 1 | 2016 | 1282 | 0.020 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2015 | 604 | 0.020 |
Why?
|
Random Allocation | 1 | 2016 | 2429 | 0.020 |
Why?
|
Chemokine CCL2 | 1 | 2013 | 617 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2006 | 5974 | 0.020 |
Why?
|
Ligands | 1 | 2017 | 3282 | 0.020 |
Why?
|
HLA Antigens | 1 | 2016 | 1381 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2016 | 1641 | 0.020 |
Why?
|
Endothelial Cells | 2 | 2016 | 3479 | 0.020 |
Why?
|
Obesity | 2 | 2013 | 12745 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2022 | 3690 | 0.020 |
Why?
|
Body Weight | 2 | 2013 | 4669 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2018 | 6314 | 0.020 |
Why?
|
Autophagy | 1 | 2018 | 1300 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2018 | 1988 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3638 | 0.020 |
Why?
|
Vascular Malformations | 1 | 2015 | 454 | 0.020 |
Why?
|
Pilot Projects | 1 | 2023 | 8324 | 0.020 |
Why?
|
Lymphocyte Transfusion | 1 | 2000 | 236 | 0.020 |
Why?
|
Angiogenesis Inhibitors | 1 | 2020 | 2038 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2021 | 3617 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2018 | 1373 | 0.020 |
Why?
|
Microscopy | 1 | 2014 | 903 | 0.020 |
Why?
|
Histocompatibility Antigens | 1 | 2010 | 471 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2016 | 1836 | 0.020 |
Why?
|
Adipocytes | 1 | 2016 | 1184 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 1434 | 0.020 |
Why?
|
Cell Communication | 1 | 2016 | 1621 | 0.020 |
Why?
|
DNA Repair | 1 | 2018 | 2046 | 0.020 |
Why?
|
Reference Values | 1 | 2016 | 4982 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2006 | 2077 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2017 | 4204 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2019 | 4803 | 0.020 |
Why?
|
Time Factors | 4 | 2018 | 40075 | 0.020 |
Why?
|
Protein Kinase C-delta | 1 | 2008 | 123 | 0.020 |
Why?
|
Inflammation | 1 | 2008 | 10638 | 0.020 |
Why?
|
Microcirculation | 1 | 2003 | 1286 | 0.020 |
Why?
|
Receptors, Virus | 1 | 2001 | 648 | 0.020 |
Why?
|
Adoptive Transfer | 1 | 2000 | 844 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2006 | 2309 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2016 | 2012 | 0.020 |
Why?
|
3T3-L1 Cells | 1 | 2008 | 198 | 0.020 |
Why?
|
Cell Cycle | 1 | 2016 | 2967 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2006 | 2132 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2020 | 2214 | 0.020 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2008 | 281 | 0.020 |
Why?
|
Methylation | 1 | 2010 | 1106 | 0.020 |
Why?
|
Macrophages | 1 | 2022 | 5655 | 0.020 |
Why?
|
Cell Lineage | 1 | 2016 | 2504 | 0.020 |
Why?
|
Multienzyme Complexes | 1 | 2010 | 686 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2014 | 2007 | 0.020 |
Why?
|
Abdomen | 1 | 2003 | 1118 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2016 | 3505 | 0.020 |
Why?
|
Streptozocin | 1 | 2006 | 196 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2016 | 2421 | 0.020 |
Why?
|
Recurrence | 1 | 2017 | 8340 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2016 | 2183 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2006 | 3798 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9734 | 0.020 |
Why?
|
Mice, SCID | 1 | 2000 | 2716 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2849 | 0.020 |
Why?
|
PPAR gamma | 1 | 2008 | 493 | 0.020 |
Why?
|
Osteopontin | 1 | 2006 | 296 | 0.020 |
Why?
|
Prospective Studies | 2 | 2020 | 53288 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2008 | 1866 | 0.020 |
Why?
|
Hypertrophy | 1 | 2006 | 569 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 7913 | 0.020 |
Why?
|
DNA | 1 | 2018 | 7301 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2020 | 4253 | 0.010 |
Why?
|
HeLa Cells | 1 | 2010 | 3128 | 0.010 |
Why?
|
Systole | 1 | 2006 | 958 | 0.010 |
Why?
|
Sex Factors | 1 | 2018 | 10397 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12788 | 0.010 |
Why?
|
Chronic Disease | 1 | 2018 | 9146 | 0.010 |
Why?
|
Isoantigens | 1 | 2006 | 567 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2006 | 11725 | 0.010 |
Why?
|
Albuminuria | 1 | 2006 | 682 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8388 | 0.010 |
Why?
|
Genotype | 1 | 2006 | 12951 | 0.010 |
Why?
|
Binding Sites | 1 | 2010 | 6114 | 0.010 |
Why?
|
Transplantation | 1 | 2003 | 217 | 0.010 |
Why?
|
Age Factors | 1 | 2018 | 18370 | 0.010 |
Why?
|
Transplantation Chimera | 1 | 2003 | 612 | 0.010 |
Why?
|
Decision Making | 1 | 2014 | 3887 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14722 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2008 | 2187 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 19905 | 0.010 |
Why?
|
Genomics | 1 | 2016 | 5720 | 0.010 |
Why?
|
Leptin | 1 | 2008 | 1599 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 12959 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2013 | 3864 | 0.010 |
Why?
|
Jejunum | 1 | 2001 | 480 | 0.010 |
Why?
|
Blood Glucose | 1 | 2013 | 6256 | 0.010 |
Why?
|
Insulin | 1 | 2013 | 6580 | 0.010 |
Why?
|
Risk Factors | 2 | 2016 | 72290 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2010 | 13815 | 0.010 |
Why?
|
Homeostasis | 1 | 2008 | 3340 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2010 | 18111 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4751 | 0.010 |
Why?
|
Cell Division | 1 | 2003 | 4568 | 0.010 |
Why?
|
Diet | 1 | 2013 | 7939 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2001 | 7880 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2003 | 3772 | 0.010 |
Why?
|
Risk Assessment | 1 | 2015 | 23338 | 0.010 |
Why?
|
Blood Pressure | 1 | 2010 | 8554 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20129 | 0.010 |
Why?
|